{"schema_version":"secwatch.filing_event.v1","accession":"0001818331-25-000002","form_type":"8-K","ticker":"WGS","cik":"0001818331","company_name":"GeneDx Holdings Corp.","filed_at":"2025-01-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.039228+00:00","generated_at":"2026-05-28T18:49:42.374401+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"GeneDx appoints Bryan Dechairo as COO with $450K salary and $2.7M RSU award","bullets":["Bryan Dechairo appointed COO effective Jan 2, 2025; reports to CEO Katherine Stueland.","Total annual base salary of $450,000 plus target annual bonus of 50% of base salary.","RSUs with $2.7M grant-date value vesting over 4 years; sign-on bonuses of $75K each in 2025 and 2026.","Dechairo previously CEO of Sherlock Biosciences; will oversee Product & Technology, Operations, Medical Affairs, Innovation."],"urls":{"canonical":"https://secwatch.observer/filing/0001818331-25-000002","json":"https://secwatch.observer/filing/0001818331-25-000002.json","markdown":"https://secwatch.observer/filing/0001818331-25-000002.md","text":"https://secwatch.observer/filing/0001818331-25-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818331/000181833125000002/0001818331-25-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818331/000181833125000002/wgs-20250102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T18:49:42.374401+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4cd1a04b2c","claim":"Bryan Dechairo was appointed as Chief Operating Officer at GeneDx Holdings Corp..","evidence_excerpt":"On January 2, 2025, GeneDx Holdings Corp. (the “Company”) announced the appointment of Bryan Dechairo, Ph.D., age 52, in the newly created role of Chief Operating Officer, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818331/000181833125000002/0001818331-25-000002-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Operating Officer"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}